Skip to main content
Caplight Logo









Yantai Lannacheng Biotechnology Co., Ltd.

Yantai Lannacheng Biotechnology Co., Ltd.

Private
YantaiHealthcare & Life Scienceshttps://lannacheng.com

Last Round

Series C

Jul 18, 2025

Est. Valuation

$459.14M

Total Funding Raised

$164.52M

Company Overview

Yantai Lannacheng Biotechnology Co., Ltd. operates in Healthcare & Life Sciences and is based in Yantai. Its latest recorded funding round was a Series C round in July 2025.

Yantai Lannacheng Biotechnology Co., Ltd. is a clinical-stage biotechnology company that develops radiopharmaceuticals for integrated cancer diagnosis and therapy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Imaging, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Yantai Lannacheng Biotechnology Co., Ltd. Comparables

Compare Yantai Lannacheng Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.

Yantai Lannacheng Biotechnology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Full-Life Technologies
85%
Suzhou SmartNuclide Biopharmaceutical Co., Ltd.
82%
Chengdu NewRT Medical Technology
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Yantai Lannacheng Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJul 18, 2025
Series CFeb 14, 2025
Series B ExtensionApr 25, 2024
Series BJun 27, 2023
Series AJun 8, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Yantai Lannacheng Biotechnology Co., Ltd. Investors

Notable investors and investment history

Yantai Lannacheng Biotechnology Co., Ltd. investors
InvestorRounds
China CindaSeries C
烟台财金集团Series B Extension
山东省新动能基金管理有限公司Series C
Real Power CapitalSeries C
Qianhai Fund of FundsSeries B Extension
Shenzhen Capital GroupSeries B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 18, 2025

    $68M round with participation from China Cinda and Real Power Capital.

  • Feb 14, 2025

    Raised $21M with Yantai Dongcheng Pharmaceutical Group participating.

Book a demo to see all signals

For institutional investors. Book with your work email.

Yantai Lannacheng Biotechnology Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Yantai Lannacheng Biotechnology Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Yantai Lannacheng Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Is Yantai Lannacheng Biotechnology Co., Ltd. a public or private company?

Yantai Lannacheng Biotechnology Co., Ltd. is a private company.

What is the current stock price of Yantai Lannacheng Biotechnology Co., Ltd.?

Yantai Lannacheng Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Yantai Lannacheng Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Yantai Lannacheng Biotechnology Co., Ltd. worth (valuation)?

Yantai Lannacheng Biotechnology Co., Ltd.'s valuation is estimated at $459.1M based on funding round data.

Can I buy Yantai Lannacheng Biotechnology Co., Ltd. stock?

Yantai Lannacheng Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Yantai Lannacheng Biotechnology Co., Ltd.'s last funding round?

Yantai Lannacheng Biotechnology Co., Ltd.'s most recent funding round was Series C on July 18, 2025.

Who are the main investors in Yantai Lannacheng Biotechnology Co., Ltd.?

Key investors in Yantai Lannacheng Biotechnology Co., Ltd. include Shenzhen Capital Group.

Will Yantai Lannacheng Biotechnology Co., Ltd. IPO soon?

No public IPO plans have been announced for Yantai Lannacheng Biotechnology Co., Ltd..

How can I track Yantai Lannacheng Biotechnology Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in Yantai Lannacheng Biotechnology Co., Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersYantai
Year Founded2021
Last FundingJul 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?